RecruitingNCT07118306

COPD Exacerbation Follow Up

A Multicenter Study of the Impact of a COPD Identification and Referral System on Patient Follow Up and Outcomes After an Acute COPD Exacerbation Resulting in an Emergency Department Visit or Hospitalization

Sponsor

Viz.ai, Inc.

Enrollment

485 participants

Start Date

Feb 27, 2026

Study Type

OBSERVATIONAL

Conditions

COPD, Chronic Obstructive Pulmonary Disease

Summary

The goal of this study is to evaluate the impact of implementing an AI-enabled clinical workflow tool (Viz COPD) on respiratory specialist follow up and clinical outcomes after an acute exacerbation.

Eligibility

Min Age: 40 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with copd, chronic obstructive pulmonary disease. The study is currently recruiting participants at 4 locations. People eligible for this study include aged 40 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.